Japan Suspends 1.6 Mn Doses Of Moderna Shot Over Contamination Fears


Tokyo: More than a week after the domestic distributor received reports of contaminants in some vials, Japan suspended the use of 1.63 million doses of Moderna Inc’s COVID-19 vaccine on Thursday.

The decision to stop using doses from three separate lots was made after discussion with the country’s health ministry, the Japanese drugmaker said in a statement.

Takeda is the local distributor of the vaccine developed by Cambridge, Massachusetts-based Moderna.

A Moderna spokesperson confirmed the halt of some batches in Japan and said it is currently investigating.

” Moderna confirms having been notified of cases of particulate matter being seen in drug product vials of its COVID-19 vaccine,” Moderna said in a statement.

“The company is investigating the reports and remains committed to working expeditiously with its partner, Takeda, and regulators to address this,” it added, referring to Japan’s Takeda Pharmaceutical.

Comments are closed.